Hi all,
PRLB reported Q3 recently and the stock itself has taken a beating. I thought the quarter itself was okay, but the market didn’t like management’s forward guidance.
Management guided for $53M to $56M in revenues, resulting in non-GAAP EPS in the $0.40 to $0.44 range. If we take the mid-points, management is guiding Q4 2014 for:
- Revenue of $54.5M. That would be about 24% QoQ revenue growth
- Non-GAAP EPS of $0.43. That would be about 10% QoQ EPS growth
Based on management’s EPS guidance, the forward non-GAAP EPS is $1.73. A stock price around $61 puts PRLB on a 35 forward PE.
The Table below provides a quarterly revenue, eps, gross margin summary etc. I find looking at this and the forward guidance useful.
======================================================================
Revenue Margin GAAP EPS Non-GAAP Shares Out Unique Devs
======================================================================
Q3 14 $54.6M 60.4% $0.40 $0.44 26,200,741 8,680
Q2 14 $52.9M 61.8% $0.42 $0.45 26,146,848 8,222
Q1 14 $46.1M 62.9% $0.39 $0.41 26,091,069 7,669
Q4 13 $44.0M 62.7% $0.36 $0.39 26,115,866 7,290
Q3 13 $42.0M 61.7% $0.34 $0.37 26,002,240 7,308
Q2 13 $39.7M 62.7% $0.33 $0.36 25,850,247 6,885
Q1 13 $37.3M 62.5% $0.32 $0.35 25,645,744 6,488
Q4 12 $33.6M 62.5% $0.29 $0.31 25,359,071 6,042
======================================================================
Now, the 35 forward PE can be thought of as cheap, but we don’t know if growth is actually slowing down. Management’s guidance for next quarter suggests slow down in the earnings and revenue growth. I did read the conference call transcripts and management did sound very very cautious about their growth next quarter, although they did reiterate their longer-term operating income growth rate of 25%. The tone (I didn’t hear it just read it) sounded cautious, and they said that their guidance will be conservative because of Europe and the state of European economy. Proto Labs builds prototypes and is definitely affected by economic cycles and slowdown in the economy.
Additionally, it could be growing pains. I mean growing from a $200 million revenue/annum base is much harder than growing from $50 million/annum revenue base, and they just got a new CEO and they will have a new CFO to help make the next transition. It could also be that the new CEO is setting the bar low to get a
So, if its growing pains then these prices look like great entry points. If not, and growth doesn’t come back to the 20 - 25% range, then I would think the PE multiple will shrink further.
I like the business though but don’t have that much in-depth knowledge as I only recently started following them. I have an average sized position, which I had started a week or so back.
Which way do you think the business is going to go? What are your thoughts on the quarter?
Anirban